Thrombolytic therapy in vertebrobasilar dolichoectasia patients with acute posterior circulation cerebral infarction: a case series analysis [0.03%]
基底动脉型长段扩张的后循环急性脑梗死患者溶栓治疗的安全性及有效性：病例系列分析
Qi Han,En-Bo Zhu,Guang-Lin Jin et al.
Qi Han et al.
A post-marketing surveillance study on the safety and effectiveness of recombinant antithrombin gamma in patients with congenital antithrombin deficiency in Japan [0.03%]
日本先天性抗凝血酶缺乏患者的重组抗凝血酶γ的上市后监测研究：安全性和有效性
Hidesaku Asakura,Manabu Iwabuchi,Masaki Fujita et al.
Hidesaku Asakura et al.
Two decades of prenatal diagnosis in hemophilia A and B: a systematic review of global trends and current practices [0.03%]
血友病A和B的产前诊断20年：全球趋势和当前实践的系统评价
Seyed Mehrab Safdari,Mehdi Bakhtiyaridovvombaigi,Fatemeh Damerchiloo et al.
Seyed Mehrab Safdari et al.
Background: Hemophilia A and B are severe X-linked bleeding disorders caused by variants in the F8 and F9 genes, respectively. Over the past two decades, prenatal diagnosis (PND) has become an essential component of hemop...
Trends and disparities in disseminated intravascular coagulation-related mortality among adults aged 25 and above in the U.S., 1999-2020: CDC WONDER insights [0.03%]
美国成人弥漫性血管内凝血相关死亡率的现状和差异（1999-2020年）：基于CDC WONDER数据库的分析
Muhammad Yousuf Saleem,Muhammad Salman Mustafa,Areeba Shafiq et al.
Muhammad Yousuf Saleem et al.
Background: Disseminated intravascular coagulation (DIC) is a severe, life-threatening coagulopathy often secondary to infection, malignancy, or obstetric complications. Despite advances in critical care, national pattern...
Lupus anticoagulant hypoprothrombinemia syndrome successfully treated with rituximab - case report [0.03%]
利普斯抗凝血素低凝血酶原症使用里妥昔单抗治疗效果良好-病例报告
Michael Iarossi,Angelo Rizzolo,Michèle Stanciu et al.
Michael Iarossi et al.
Multifactorial thrombotic risk in Evans syndrome: a case report and review of the literature [0.03%]
Evans综合征的多因素血栓风险：病例报告和文献回顾
Hande Nur Erolmez,Semih Eker,Fakiha Siddiqui et al.
Hande Nur Erolmez et al.
Lu Wang,Xiang Zhou;China National Critical Care Quality Control Centre Group (China-NCCQC)
Lu Wang
Hong Tham Pham,Kim-Huong Truong-Nguyen,Minh-Hoang Tran
Hong Tham Pham
Despite the recently reported real-world evidence of the signals between echinocandins and coagulation dysfunction events, there are some concerns that may impact the robustness and implications of these findings. For the study design, comb...
The relationships between disseminated intravascular coagulation and time series change of Von Willebrand factor in patients with out-of-hospital cardiac arrest: a retrospective observational study [0.03%]
院前心脏骤停患者弥漫性血管内凝血与von willebrand因子时间序列变化关系的回顾性观察研究
Yuki Itagaki,Yuki Chiba,Misako Suzuki et al.
Yuki Itagaki et al.
Hematologic safety of caplacizumab in immune-mediated thrombotic thrombocytopenic purpura: insights from platelet-related signal detection in the FAERS database [0.03%]
基于FAERS数据库血小板相关信号检测的免疫性血栓性血小板减少性紫癜患者使用caplacizumab的血液学安全性研究
Zhenqi Liu,Xu Ye
Zhenqi Liu
Background: Caplacizumab, a nanobody targeting von Willebrand factor, has transformed the management of immune-mediated thrombotic thrombocytopenic purpura (iTTP) by rapidly restoring platelet counts and improving surviva...